ATE45961T1 - Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung. - Google Patents

Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.

Info

Publication number
ATE45961T1
ATE45961T1 AT84106456T AT84106456T ATE45961T1 AT E45961 T1 ATE45961 T1 AT E45961T1 AT 84106456 T AT84106456 T AT 84106456T AT 84106456 T AT84106456 T AT 84106456T AT E45961 T1 ATE45961 T1 AT E45961T1
Authority
AT
Austria
Prior art keywords
globulin
cytomegalovirus
sum
production
methods
Prior art date
Application number
AT84106456T
Other languages
English (en)
Inventor
Milton B Dobkin
Robert E Louie
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24004864&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE45961(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Miles Inc filed Critical Miles Inc
Application granted granted Critical
Publication of ATE45961T1 publication Critical patent/ATE45961T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/085—Orthoherpesviridae (F), e.g. pseudorabies virus or Epstein-Barr virus
    • C07K16/089—Cytomegalovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT84106456T 1983-06-14 1984-06-06 Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung. ATE45961T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/504,105 US4617379A (en) 1983-06-14 1983-06-14 High titer cytomegalovirus immune serum globulin
EP84106456A EP0128522B1 (de) 1983-06-14 1984-06-06 Humanes Cytomegalovirus Immunserumglobulin mit hohem Titer und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE45961T1 true ATE45961T1 (de) 1989-09-15

Family

ID=24004864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84106456T ATE45961T1 (de) 1983-06-14 1984-06-06 Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.

Country Status (6)

Country Link
US (1) US4617379A (de)
EP (1) EP0128522B1 (de)
JP (1) JPH0625070B2 (de)
AT (1) ATE45961T1 (de)
CA (1) CA1244767A (de)
DE (1) DE3479583D1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808518A (en) * 1985-02-11 1989-02-28 University Of Tennessee Research Corporation Recovery of cytomegalovirus antigen and use thereof in an assay
US4717564A (en) * 1985-11-07 1988-01-05 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4665159A (en) * 1985-11-07 1987-05-12 Miles Laboratories, Inc. High titer varicella-zoster immune globulin for intravenous administration
US4659563A (en) * 1986-01-27 1987-04-21 Miles Laboratories, Inc. High titer anti-respiratory syncytial virus intravenous immune globulin
US4717766A (en) * 1986-01-27 1988-01-05 Miles Laboratories, Inc. Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
AU668092B2 (en) * 1991-04-22 1996-04-26 Massachusetts Health Research Institute, Inc. Process of screening plasma samples for effective antibody titers against respiratory viruses
ES2170788T3 (es) * 1995-09-22 2002-08-16 Zlb Bioplasma Ag Procedimiento para la obtencion de inmunoglobulinas a partir de fracciones que resultan de plasma sanguineo humano.
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
RU2239453C2 (ru) * 2002-12-03 2004-11-10 Федеральное государственное унитарное предприятие " Научно-производственное объединение по медицинским иммунобиологическим препаратам " Микроген" Препарат иммуноглобулина человека против цитомегаловируса и способ его получения
US6984492B2 (en) * 2003-09-05 2006-01-10 Talecris Biotherapeutics, Inc. Methods and compositions for treating herpes infections
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
WO2006119774A1 (en) * 2005-05-13 2006-11-16 Medimush As Feed or food products comprising fungal material
WO2006133707A2 (en) * 2005-06-15 2006-12-21 Medimush A/S Anti-cancer combination treatment and kit-of-part
WO2006133708A1 (en) * 2005-06-15 2006-12-21 Medimush A/S Bioactive agents produced by submerged cultivation of a basidiomycete cell
US8354249B2 (en) * 2005-08-11 2013-01-15 Omrix Biopharmaceuticals Ltd. Intravenous immunoglobulin composition
US7947274B2 (en) 2007-01-04 2011-05-24 Humabs, LLC. Human cytomegalovirus neutralising antibodies and use thereof
GB0700133D0 (en) 2007-01-04 2007-02-14 Humabs Llc Human cytomegalovirus neutralising antibodies and use thereof
WO2009005870A2 (en) * 2007-04-12 2009-01-08 Omrix Biopharmaceuticals Ltd, Products for prophylaxis and/or treatment of viral diseases and method of making and using same
US8124093B2 (en) 2008-07-16 2012-02-28 Institute For Research In Biomedicine Human cytomegalovirus neutralizing antibodies and use thereof
US20130172536A1 (en) * 2011-08-16 2013-07-04 Shenzhen Weiguang Biological Products Co.,Ltd. Intravenous Cytomegalovirus Human Immune Globulin and Manufacturing Method Thereof
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CA3050914A1 (en) * 2017-01-27 2018-08-02 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Vaccine compositions of herpesvirus envelope protein combinations to induce immune response
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903262A (en) * 1972-03-13 1975-09-02 Cutter Lab Pharmaceutical compositions comprising intravenously injectable modified serum globulin, its production and use
DE2610854A1 (de) * 1976-03-15 1977-09-22 Biotest Serum Institut Gmbh Galenische immunglobulinzubereitung
US4165370A (en) * 1976-05-21 1979-08-21 Coval M L Injectable gamma globulin
US4174388A (en) * 1977-02-14 1979-11-13 Merck & Co., Inc. Method for preparing hepatitis B immune globulin
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
US4186192A (en) * 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4371520A (en) * 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection

Also Published As

Publication number Publication date
EP0128522A3 (en) 1986-11-26
JPH0625070B2 (ja) 1994-04-06
JPS6069032A (ja) 1985-04-19
CA1244767A (en) 1988-11-15
EP0128522A2 (de) 1984-12-19
US4617379A (en) 1986-10-14
EP0128522B1 (de) 1989-08-30
DE3479583D1 (en) 1989-10-05

Similar Documents

Publication Publication Date Title
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
ATE49219T1 (de) Pseudomonas immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
NO20002413L (no) Antistoffer mot Moraxella proteiner og anvendelse derav, samt sett for pÕvisning av antigen og farmasøytisk preparat som inneholder antistoffer
DK0726758T3 (da) Peptider til inducering af cytotoksiske T-lymfocytreaktioner over for hepaptitis B virus
ATE166230T1 (de) Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
OA09889A (en) Peptides for inducing-cytotoxic T-lymphocyte responses to hepatitis B virus.
Mifune et al. Essential role of T cells in the postexposure prophylaxis of rabies in mice
ATA118995A (de) Humanes virussicheres monomeres immunglobulin a und verfahren zu seiner herstellung
ATA171686A (de) Verfahren zur herstellung von gegen pseudomonas aeruginosa infektionen wirksamen praeparationen
WO2002057314A3 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
EP0674905A3 (de) Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung.
ATE122100T1 (de) Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen.
Naveh et al. Large scale downstream processing of monoclonal antibodies.
DE69025629D1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids-verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DE3679255D1 (de) Behandlung chronischer entzuendungskrankheiten.
Gordon Intravenous immunoglobulin: Historical perspective
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
Odendaal et al. The passive protection of lambs against Clostridium perfringens type D with semi-purified hyperimmune serum
Steinberg et al. Is immunoglobulin E a “gatekeeper” for other antibodies?
Bakay et al. Immunoenhancement and suppresion induced by adenovirus in chicken
DE68913932D1 (de) Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung.
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
Mozen HIV inactivation in plasma products
ATE126704T1 (de) Bcrf1-antagonisten zur behandlung von epstein- barr-virus-infektionen.
Skurkovich et al. Production of monospecific immunoglobulin against human leukocyte interferon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
RZN Patent revoked